<bill session="116" type="h" number="5381" updated="2022-10-28T01:46:00Z">
  <state datetime="2019-12-10">REFERRED</state>
  <status>
    <introduced datetime="2019-12-10"/>
  </status>
  <introduced datetime="2019-12-10"/>
  <titles>
    <title type="display">International Pharmaceutical Transparency Act of 2019</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug to list the country of origin of each of the drug's active ingredients.</title>
    <title type="short" as="introduced">International Pharmaceutical Transparency Act of 2019</title>
  </titles>
  <sponsor bioguide_id="D000616"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-12-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-12-10" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-12-11">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-13T19:51:11Z" status="Introduced in House">International Pharmaceutical Transparency Act of 2019

This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.</summary>
</bill>
